While ROMA improves diagnostic accuracy, it is not without its limitations. The algorithm may not be as effective in distinguishing between borderline tumors and malignant tumors. Additionally, factors like renal insufficiency and other chronic conditions can affect biomarker levels, potentially leading to false positives or false negatives.
